More than 5,200 confirmed Ebola cases. Nearly 2,500 deaths. Six provinces affected. Cases detected beyond the Democratic Republic of the Congo.
Those numbers are alarming, and the Ebola outbreak now unfolding in Central Africa deserves international attention. But they don’t necessarily mean the world is heading toward another global pandemic.
As of August 18, the European Centre for Disease Prevention and Control (ECDC) reported 5,208 confirmed cases and 2,476 deaths in the DRC, putting the case-fatality rate at roughly 47.5%. The outbreak has reached 56 health zones across six provinces.
It is now the largest and deadliest Ebola outbreak in DRC history and the second-largest Ebola outbreak recorded globally, behind only the devastating 2014–2016 West Africa epidemic.
So should people in Israel, Europe and North America start worrying?
The short answer is: the outbreak is extremely serious, but the current evidence does not suggest that ordinary people outside the affected region face a significant immediate risk.
What Is Happening in the DRC?
The outbreak was officially declared by Congolese authorities on May 15 after laboratory testing identified Bundibugyo ebolavirus (BDBV).
That’s an important distinction.
Most people associate Ebola with Zaire ebolavirus, the species responsible for the enormous 2014–2016 West Africa epidemic. The current outbreak involves the rarer Bundibugyo species.
It began in Ituri Province in northeastern DRC and subsequently spread into North Kivu, South Kivu, Haut-Uélé, Tshopo and Bas-Uélé.
Ituri remains the center of the epidemic.
The speed of transmission has become particularly concerning. During the week of August 3–9 alone, WHO recorded 579 new confirmed cases and 304 deaths, the highest weekly totals of the outbreak at that point.
WHO has warned that transmission in some affected areas is occurring faster than infected people can be detected and isolated.
By mid-August, WHO Director-General Tedros Adhanom Ghebreyesus described the epidemic as “far from being under control.”
Why This Outbreak Is Different
The numbers have already passed those of the DRC’s previous major Ebola epidemic.
The 2018–2020 outbreak in North Kivu and Ituri caused approximately 3,400 cases and 2,299 deaths. The current outbreak has exceeded both figures in a matter of months.
Only one Ebola epidemic has been larger: the 2014–2016 West Africa outbreak, which resulted in approximately 28,600 cases and more than 11,300 deaths, principally in Guinea, Liberia and Sierra Leone.
There is another complication.
The licensed Ebola vaccine Ervebo was developed against Zaire ebolavirus. There is currently no approved vaccine specifically proven to prevent Bundibugyo Ebola, nor an approved antiviral treatment specifically established against this species.
Researchers are testing potential vaccines and treatments, while WHO and Africa CDC have also allocated Ervebo doses for targeted use and research into possible cross-protection.
In the meantime, early supportive medical care remains crucial and can significantly improve a patient’s chances of survival.
Ebola Has Already Reached Other Countries
International cases understandably raise fears that the outbreak could escape Central Africa.
Uganda recorded 20 confirmed cases and two deaths linked to the outbreak. However, Uganda subsequently brought transmission under control and declared its outbreak over on July 28.
France also detected an imported case in a traveler from the DRC. The patient was isolated, and WHO reported no secondary transmission.
Two people infected in the DRC were separately medically evacuated to Germany for treatment. These were not infections acquired inside Germany.
As of August 21, there was no documented sustained Ebola transmission in Europe, Israel or North America.
That distinction is crucial.
A person arriving in another country while infected with Ebola is concerning, but it is very different from Ebola establishing an ongoing chain of community transmission there.
Why Ebola Is Unlikely to Become the Next COVID
Ebola is extraordinarily dangerous once someone becomes infected, but it does not spread nearly as easily as viruses such as COVID-19 or measles.
Transmission occurs primarily through direct contact with the blood or other bodily fluids of a symptomatic infected person, or through objects contaminated with those fluids.
Ebola does not ordinarily spread through the air.
Another major difference is timing.
People infected with Ebola generally become contagious after symptoms develop. The incubation period can range from two to 21 days, but an infected traveler who has not yet developed symptoms is not generally considered infectious.
That gives health authorities an important advantage.
Once a suspected patient develops symptoms, authorities can isolate the person, test them, identify their contacts and monitor those contacts for symptoms.
This is one reason even the enormous 2014–2016 West Africa epidemic, with more than 28,000 cases, never developed into sustained worldwide transmission.
Imported cases occurred, including in the United States and Europe, but Ebola did not begin circulating broadly among those populations.
What Is the Risk to Europe?
For Europeans, the current assessment is reassuring.
On August 19, the ECDC assessed the likelihood of infection for people in the EU and European Economic Area as “very low.”
That does not mean imported cases are impossible. France has already demonstrated that an infected traveler can reach Europe.
It means that the combination of Ebola’s transmission characteristics and the ability of developed healthcare systems to detect and isolate suspected cases makes widespread transmission unlikely under present conditions.
What About Israel?
Israel has also been preparing for the possibility of an imported case.
The Health Ministry held readiness discussions as the African outbreak expanded and assessed the risk of an Ebola outbreak in Israel as low.
Two suspected cases were investigated in Israel in June, involving patients treated at Rambam Medical Center in Haifa and Sheba Medical Center in Ramat Gan.
Both tested negative for Ebola.
As of August 21, Israel had recorded no confirmed case connected to the outbreak.
There is always a theoretical possibility that an infected traveler could reach Israel through international air travel. But an imported infection would not automatically mean an outbreak.
Israeli hospitals and health authorities would instead focus on rapid diagnosis, isolation, protective equipment and contact tracing.
Why Is the DRC Struggling to Stop It?
The biggest danger right now remains inside Central Africa.
Eastern DRC presents almost every condition that makes Ebola containment difficult: insecurity, population displacement, frequent movement between communities and across borders, overstretched medical facilities and gaps in contact tracing.
Some patients have died at home without reaching treatment centers. Authorities have also encountered infections whose transmission chains could not immediately be identified.
Healthcare workers themselves have been infected.
WHO has warned that treatment capacity in some areas is under severe pressure.
This creates a vicious cycle: when patients aren’t identified quickly enough, they can infect relatives, caregivers and healthcare workers before being isolated.
That’s why the outbreak demands a major international response even if the immediate danger to someone living thousands of kilometers away remains small.
What Would Make the Outbreak Much More Concerning?
There are several developments that would change the international risk calculation.
The most important would be sustained transmission outside the DRC.
One infected traveler reaching France is manageable. An infected traveler starting a chain in which several generations of people become infected locally would be much more significant.
Other warning signs would include outbreaks becoming established in several neighboring countries, major transmission in densely populated cities, collapsing contact-tracing systems or treatment centers becoming unable to accommodate patients.
Researchers are also watching the effectiveness of experimental vaccines and treatments against Bundibugyo Ebola.
And there is one hypothetical development that would radically alter the situation: evidence that the virus had become capable of efficient airborne or pre-symptomatic transmission.
There is currently no evidence that this has happened.
Concern Is Justified. Panic Isn’t.
The scale of the outbreak shouldn’t be minimized.
Thousands of people have already been infected, nearly half of confirmed patients have died, and health authorities are fighting an epidemic that has expanded extraordinarily quickly across eastern DRC.
For communities in the affected region, this is already a catastrophe.
For the rest of the world, however, the question is different.
Could infected travelers reach other countries? Yes. It has already happened.
Could additional imported cases occur? Absolutely.
But does the evidence currently suggest that people in Tel Aviv, London, Paris, Toronto or New York face a meaningful risk of contracting Ebola during ordinary daily life?
No.
Ebola’s devastating mortality makes it frightening, but its method of transmission also makes it considerably easier to contain than highly contagious respiratory viruses.
The world should therefore be paying close attention to what happens next in the DRC, supporting efforts to bring the outbreak under control and watching carefully for international transmission.
For now, the evidence points toward vigilance rather than panic.
